A couple of drug companies have grim outlooks thanks to patents expiring on popular drugs, while one company's innovation has come under heavy scrutiny. All three face tough times ahead...
Here's what analysts had to say about these companies today...
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
Here's what analysts had to say about these companies today...
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
Headlines you need to know this morning…
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
Headlines you need to know this morning…